# PharmaCyte Biotech, Inc.: Form DEF 14A, filed Oct 6, 2025

- Company: [PharmaCyte Biotech, Inc.](/companies/pmcb.md) (CIK 1157075)
- Form: DEF 14A
- Filed: 2025-10-06
- Accepted by EDGAR: Oct 6, 2025, 21:08 ET
- Period: 2025-10-30
- Accession: 0001683168-25-007435
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1157075/000168316825007435/pharmacyte_def14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1157075/000168316825007435/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1157075/000168316825007435/pharmacyte_def14a.htm

Filed Oct 6, 2025.
Source: SEC EDGAR, the filing index for accession 0001683168-25-007435. Last ingested by Listed: Oct 24, 2026, 15:05 ET. No prices; not investment advice.